Cancers 2011, 3(4), 3894-3908; doi:10.3390/cancers3043894
Review

The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer

Received: 13 September 2011; in revised form: 7 October 2011 / Accepted: 9 October 2011 / Published: 14 October 2011
(This article belongs to the Special Issue Exploring Inflammation in Cancers)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Colorectal cancer (CRC) is now the second-leading cause of cancer deaths in the USA. Colorectal cancer progression and metastasis depends on the orchestration of the aberrant signaling pathways that control tumor cell proliferation, survival and migration/invasion. Epidemiological, clinical, and animal studies have demonstrated that prostaglandin-endoperoxide synthase 2 (PTGS2) and epithelial growth factor (EGF) signaling pathways play key roles in promoting colorectal cancer growth and metastasis. In this review, we highlight major advances in our understanding of the roles of PTGS2 and EGF signaling in colorectal cancer.
Keywords: PTGS2; COX-2; EGFR; colorectal cancer
PDF Full-text Download PDF Full-Text [231 KB, uploaded 14 October 2011 09:56 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Wang, D.; Xia, D.; DuBois, R.N. The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer. Cancers 2011, 3, 3894-3908.

AMA Style

Wang D, Xia D, DuBois RN. The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer. Cancers. 2011; 3(4):3894-3908.

Chicago/Turabian Style

Wang, Dingzhi; Xia, Dianren; DuBois, Raymond N. 2011. "The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer." Cancers 3, no. 4: 3894-3908.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert